JS
Joseph Stringer, Ph.D. is a Senior Analyst at Needham & Company, specializing in biotechnology. He joined Needham in 2017 after working as a research scientist at Ra Pharmaceuticals and completing postdoctoral research at Yale University.
Score over time
The PunditScore after each graded call, on the panel's score bands.Hover a point to read the call. Click to pin it.
AXIS
Still open · 16
THE FRONT EDGENot resolved, so they don’t move the score.
?No market prices this claim
Sign in to read this call.
Due Dec 31, 2026Said January 7, 2026BiotechVaccine
?No market prices this claim
Sign in to read this call.
Due Mar 31, 2027 (12 months assumed)Said March 2026BiotechnologyPharmaceuticals
?No market prices this claim
Sign in to read this call.
Due Apr 30, 2027 (12 months assumed)Said April 2026BiotechnologyPharmaceuticals
?No market prices this claim
Sign in to read this call.
Due Apr 30, 2027 (12 months assumed)Said April 2026BiotechnologyPharmaceuticals
?No market prices this claim
Sign in to read this call.
Due May 15, 2027 (12 months assumed)Said May 15, 2026BiotechPharmaceuticals
?No market prices this claim
Joseph Stringer predicts Ionis Pharmaceuticals will reach a price of $86.00, indicating a 42.67% upside.
Due Jul 29, 2027 (12 months assumed)Said July 29, 2026PharmaceuticalsIonis
?No market prices this claim
Joseph Stringer predicts Alnylam Pharma will reach a price of $357.00, indicating a 47.39% upside.
Due Jul 30, 2027 (12 months assumed)Said July 30, 2026PharmaceuticalsAlnylam
?No market prices this claim
Annexon Inc will reach a price of $25.00.
Due Aug 1, 2027Said August 2026BiotechnologyPharmaceuticals
?No market prices this claim
Vaxcyte Inc will reach a price of $110.00.
Due Aug 31, 2027Said September 2026BiotechnologyPharmaceuticals
?No market prices this claim
Inflarx Nv will reach a price of $8.00.
Due Aug 31, 2027Said September 2026BiotechnologyPharmaceuticals
?No market prices this claim
Gilead Sciences Inc will reach a price of $170.00.
Due Aug 31, 2027 (12 months assumed)Said August 2026BiotechnologyPharmaceuticals
?No market prices this claim
Bioage Labs Inc will reach a price of $35.00.
Due Aug 31, 2027 (12 months assumed)Said August 2026BiotechnologyPharmaceuticals
?No market prices this claim
Ionis Pharmaceuticals Inc will reach a price of $86.00.
Due Sep 30, 2027 (12 months assumed)Said September 2026BiotechnologyPharmaceuticals
?No market prices this claim
Ionis Pharmaceuticals will bolster future earnings due to lucrative licensing deals with Ono and Sobi.
Said October 2026Healthcare
?No market prices this claim
Sign in to read this call.
Said May 15, 2026BiotechPharmaceuticals
?No market prices this claim
Pelacarsen will generate about $2.7 billion in peak, non-risk-adjusted sales, translating into roughly $615 million in peak royalty revenue for Ionis.
Said May 15, 2026BiotechPharmaceuticals